BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17240036)

  • 1. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.
    Patard JJ; Pantuck AJ; Crepel M; Lam JS; Bellec L; Albouy B; Lopes D; Bernhard JC; Guillé F; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferriere JM; Abbou CC; Colombel M; Belldegrun AS
    Eur Urol; 2007 Jul; 52(1):148-54. PubMed ID: 17240036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Do broader indications for partial nephrectomy result in excess morbidity?].
    Verhoest G; Crepel M; Bernhard JC; Bellec L; Albouy B; Lopes D; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferrière JM; Abbou CC; Colombel M; Vincendeau S; Bensalah K; Manunta A; Guillé F; Patard JJ
    Prog Urol; 2008 Apr; 18(4):207-13. PubMed ID: 18501300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Bensalah K; Pantuck AJ; Rioux-Leclercq N; Thuret R; Montorsi F; Karakiewicz PI; Mottet N; Zini L; Bertini R; Salomon L; Villers A; Soulie M; Bellec L; Rischmann P; De la Taille A; Avakian R; Crepel M; Ferriere JM; Bernhard JC; Dujardin T; Pouliot F; Rigaud J; Pfister C; Albouy B; Guy L; Joniau S; van Poppel H; Lebret T; Culty T; Saint F; Zisman A; Raz O; Lang H; Spie R; Wille A; Roigas J; Aguilera A; Rambeaud B; Martinez Piñeiro L; Nativ O; Farfara R; Richard F; Roupret M; Doehn C; Bastian PJ; Muller SC; Tostain J; Belldegrun AS; Patard JJ
    Eur Urol; 2010 Mar; 57(3):466-71. PubMed ID: 19359089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic variables to predict cancer-related death in incidental renal tumours.
    Bensalah K; Pantuck AJ; Crepel M; Verhoest G; Méjean A; Valéri A; Ficarra V; Pfister C; Ferrière JM; Soulié M; Cindolo L; De La Taille A; Tostain J; Chautard D; Schips L; Zigeuner R; Abbou CC; Lobel B; Salomon L; Lechevallier E; Descotes JL; Guillé F; Colombel M; Belldegrun AS; Patard JJ
    BJU Int; 2008 Nov; 102(10):1376-80. PubMed ID: 18727618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm.
    Becker F; Siemer S; Hack M; Humke U; Ziegler M; Stöckle M
    Eur Urol; 2006 Jun; 49(6):1058-63; discussion 1063-4. PubMed ID: 16630686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imperative and elective indications for nephron-sparing surgery for renal tumors: long-term oncological follow-up.
    Roos FC; Pahernik S; Brenner W; Thüroff JW
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S70-6. PubMed ID: 20094960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is the clinical practice of partial nephrectomy in France?].
    Bernhard JC; Ferriere JM; Crepel M; Wallerand H; Bellec L; Lacroix B; Lopes D; Albouy B; Robert G; Ravaud A; Colombel M; Tostain J; Pfister C; Soulie M; Salomon L; De La Taille A; Pasticier G; Abbou CC; Manunta A; Guille F; Patard JJ
    Prog Urol; 2008 Jul; 18(7):428-34. PubMed ID: 18602602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.
    Gratzke C; Seitz M; Bayrle F; Schlenker B; Bastian PJ; Haseke N; Bader M; Tilki D; Roosen A; Karl A; Reich O; Khoder WY; Wyler S; Stief CG; Staehler M; Bachmann A
    BJU Int; 2009 Aug; 104(4):470-5. PubMed ID: 19239445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
    Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH; Jain S; Benway BM; Figenshau RS
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up.
    Denzinger S; Ganzer R; Fink A; Wieland WF; Blana A
    Scand J Urol Nephrol; 2007; 41(6):496-500. PubMed ID: 17853016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.